DM Neurology – National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru
DrNB Neurology – National Board of Examinations (NBE)
MD (Internal Medicine) – VS Hospital, Ahmedabad
MBBS - Govt Medical College, Baroda
PDF – Post-Doctoral Fellowship in Parkinson’s Disease & Movement Disorders
FIHN – Fellowship in Interventional Headache Neurology- World Headache Society
FEBN – Fellowship of the European Board of Neurology (UEMS)
MRCP SCE (Neurology) – Royal College of Physicians (England)
Post-PG Diploma in Neurotology
Post-PG Diploma in Neuro-Ophthalmology
PGCC in Dementia (Uni. Bradford)
Senior Teaching Fellow (World Headache Society)
Consultant Neurologist, KD Hospital
Associate Consultant, Department of Neurology, Artemis Hospital, Gurugram
Fellow, Parkinson’s Disease and Movement Disorders, Artemis Hospital, Gurugram
Senior Registrar, National Institute of Mental Health and Neuro Sciences (NIMHANS), Bengaluru
Residency in Internal Medicine, VS and SVP Hospital, Ahmedabad
Parkinson’s disease and atypical parkinsonian disorders
Tremor, dystonia, tics, chorea, myoclonus and other movement disorders
Functional movement disorders and complex gait disorders
Botulinum toxin therapy for movement disorders, spasticity and sialorrhoea
Deep Brain Stimulation (DBS) evaluation, post-operative management and programming
Neurological assessment for selected lesion-based surgical therapies
Interventional headache procedures, including peripheral cranial nerve blocks and SPG block
Botulinum toxin therapy for chronic migraine and selected refractory trigeminal neuralgia
Ranked 12th nationally in the Institute of National Importance Super-Specialty Entrance Examination
First Prize – Departmental Neurology Quiz, NIMHANS, 2024
Selected for Zonal Rounds – Torrent Young Scholar Awards in Neurology, 2025
NESSAN- EEG Certification
Contributor to three Book Chapters
DM Dissertation: “Clinical, Genetic, Chorio-retinal and Electrophysiological Profile in Paediatric-Onset Cerebellar Ataxia of Probable Genetic Etiology.”
Mixed Movement Disorder in a Patient With a Novel Biallelic KCNMA1 Splice Site Variant: Expanding the Genotype-Phenotype Correlation, Journal of Movement Disorders. 2026.
Journey Through Autosomal-Recessive Spastic Ataxia of Charlevoix–Saguenay: Insights From a Case Series, Journal of Movement Disorders. 2024;17(4):430–435.
Ataxia With Oculomotor Apraxia: A Case Series From a Tertiary Care Centre in India, Movement Disorders in Clinical Practice. 2025.
Abdominal Angina Secondary to Abdominal Aortic Stenosis in a Case of Takayasu Arteritis, Journal of the Association of Physicians of India. 2021.
A Case of Diffuse Cystic Lung Disease in a Patient With COVID-19, International Journal of Scientific Research. 2020; 9(12).
What is the difference between Parkinson’s disease and other movement disorders such as dystonia?
Parkinson’s disease and dystonia are different movement disorders, although some symptoms may overlap. Parkinson’s disease is characterized principally by bradykinesia (slowness of movement), usually with rigidity and/or rest tremor, and may later cause problems with gait, balance, speech, and other non-motor functions. Dystonia is characterized by involuntary, sustained or intermittent muscle contractions that produce abnormal movements or postures. Dystonia may affect a single body region, such as the neck or eyelids, or involve multiple regions. Accurate diagnosis depends on careful assessment of the movement pattern, its timing, triggers, associated features, and neurological examination, as treatment differs considerably between these conditions.
How are chronic migraines and difficult-to-treat headaches evaluated and managed?
Chronic or difficult-to-treat headaches require more than simply treating the pain. A detailed assessment is performed to establish the type of headache, its frequency and pattern, associated symptoms, triggers, medication use, and any warning features suggesting a secondary cause. Medication-overuse headache is also important to identify in patients who frequently use acute pain-relieving medicines. Management is individualized and may include lifestyle measures, appropriate acute treatment, preventive medications, and, when indicated, specialist treatments such as botulinum toxin therapy for chronic migraine, occipital or supraorbital nerve blocks, trigger-point procedures, or other targeted interventions. The aim is not only to reduce headache days but also to improve function and quality of life.
What are the key warning signs of a stroke or Transient Ischemic Attack (TIA)?
Stroke or TIA should be suspected when neurological symptoms develop suddenly, particularly facial weakness or drooping, weakness or numbness of an arm or leg (especially on one side), difficulty speaking or understanding speech, sudden loss or blurring of vision, new severe imbalance, or difficulty walking. A TIA can cause similar symptoms that completely resolve, but it should not be ignored because it may be a warning sign of an impending stroke. Stroke is a medical emergency, and patients with sudden neurological symptoms should seek immediate emergency medical evaluation rather than waiting for symptoms to improve. Early assessment is critical because some treatments are highly time-dependent.
When should a patient consult a neurologist for memory decline or cognitive changes?
Occasional forgetfulness can occur with ageing, stress, poor sleep, or other common factors. However, a neurological evaluation is advisable when memory problems are progressive, noticeably different from a person's previous level of functioning, or begin to interfere with everyday activities. Difficulty managing finances or medications, getting lost in familiar places, problems finding words, impaired judgment or planning, personality or behavioural changes, or difficulty performing previously familiar tasks may all warrant assessment. Evaluation helps distinguish between mild cognitive impairment, different forms of dementia, and potentially reversible causes such as metabolic disorders, nutritional deficiencies, medication effects, sleep disorders, or other neurological conditions. Early diagnosis allows appropriate treatment, risk-factor modification, counselling, and future planning.
